Marshall Fordyce, President and CEO at Vera Therapeutics, Inc. (VERA), sold 63,094 shares at $21.69 ($1.3M) on 2022-10-04, disclosed to the SEC on 2022-10-05.
Open-market sale of $1.3M VERA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.39 | 11,369 | $232K | 17.6% |
| 2 | $20.39 | 11,369 | $232K | 17.6% |
| 3 | $21.16 | 2,408 | $51K | 3.9% |
| 4 | $21.16 | 2,408 | $51K | 3.9% |
| 5 | $20.29 | 6,899 | $140K | 10.6% |
| 6 | $20.29 | 6,899 |
| $140K |
| 10.6% |
| 7 | $21.69 | 10,418 | $226K | 17.2% |
| 8 | $21.69 | 10,418 | $226K | 17.2% |
| 9 | $22.19 | 906 | $20K | 1.5% |
| Total | $20.88 avg | 63,094 | $1.3M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |